Upper and lower body adipose tissue (AT) exhibits opposing associations with obesity-related cardiometabolic diseases. Recent studies have suggested that altered AT oxygen tension (pO 2 ) may contribute to AT dysfunction. Here, we compared in vivo abdominal (ABD) and femoral (FEM) subcutaneous AT pO 2 in women who are overweight and have obesity, and investigated the effects of physiological AT pO 2 on human adipocyte function.
insulin resistance, and the development of chronic cardiometabolic diseases (1) (2) (3) . However, the inciting event(s) underlying the metabolic and endocrine derangements in human AT are still not fully understood.
Recent evidence indicates that AT oxygen tension (pO 2 ) may affect AT function (4) . Although the importance of oxygen availability in key metabolic organs has not been investigated extensively, alterations in AT pO 2 have been linked to metabolic impairments (4) (5) (6) . We have previously shown that AT pO 2 is higher in individuals with obesity (;9% O 2 ) than in lean (;6% O 2 ) individuals and is positively associated with insulin resistance (7), independently of adiposity in men and women with obesity (8) . More recently, we demonstrated that diet-induced weight loss decreased AT pO 2 in humans, which was accompanied by improved insulin sensitivity (9) . Noteworthy, findings on AT oxygenation in human obesity are conflicting (10, 11) .
Several studies have shown that acute exposure of (pre)adipocytes to hypoxia, especially severe hypoxia (1% O 2 ), evokes a proinflammatory phenotype (12) (13) (14) (15) . In contrast, chronic exposure to severe hypoxia increased triacylglycerol accumulation and improved insulin sensitivity in 3T3-L1 adipocytes (16) . Moreover, exposure of differentiating abdominal (ABD) adipocytes to human physiological pO 2 levels altered adipokine expression/ secretion and adipocyte lipolysis compared with 21% O 2 (17) , suggesting that pO 2 in the AT microenvironment determines adipocyte functionality.
Next to total AT mass and function, body fat distribution is an important determinant of cardiometabolic health (18, 19) . ABD obesity is associated with an increased risk of developing type 2 diabetes and cardiovascular diseases (20) . In contrast, lower body fat has protective properties that are associated with an improved cardiometabolic risk profile in men and women (21) (22) (23) . However, underlying mechanisms for the apparent functional differences between upper and lower body AT remain elusive. It is tempting to postulate that depot differences in AT pO 2 contribute to distinct metabolic and inflammatory signatures of these AT depots and, therefore, the metabolic risk associated with a certain body fat distribution.
Here, we compared in vivo ABD and femoral (FEM) subcutaneous (sc) AT pO 2 and ATBF in well-phenotyped postmenopausal women who are overweight with obesity and impaired glucose metabolism. Mechanistically, we investigated depot-specific effects of prolonged physiological AT pO 2 exposure on adipokine expression and secretion, oxygen consumption rate (OCR), and glucose uptake in differentiated human multipotent adiposederived stem (hMADS) cells derived from ABD and FEM scAT from the same individuals.
Materials and Methods

Participants
Eight [body mass index (BMI) $28 kg/m 2 ] postmenopausal women who were overweight with obesity (aged 40 to 65 years) and impaired glucose metabolism were recruited by public advertisements. Exclusion criteria were smoking, cardiovascular disease, type 2 diabetes mellitus, liver or kidney disease, use of medication known to affect body weight and glucose metabolism, and marked alcohol consumption (.14 alcoholic units/week). Furthermore, participants had to be weight stable (weight change ,3.0 kg) for at least 3 months prior to the start of the study.
The study was performed according to the Declaration of Helsinki and approved by the Medical-Ethical Committee of Maastricht University. All participants gave written informed consent before participation in the study.
Anthropometric measurements
On the first visit, body weight, height, and waist (top of the iliac crest) and hip (widest portion of the buttocks) circumferences were measured, and blood pressure was assessed (Intellisense Omron Model M6 comfort; Omron Healthcare Inc., Vernon Hills, IL). Body composition and body fat distribution were determined by dual energy x-ray absorptiometry (QDR 4500-A; Hologic, Waltham, MA).
Continuous monitoring of ABD and FEM scAT pO 2
ABD and FEM scAT pO 2 were simultaneously monitored in vivo under fasting conditions on the first visit using a validated two-channel optochemical measurement system (7, 24) . Briefly, the system consists of microdialysis catheters for the extraction of interstitial fluid, miniaturized flow-through cells containing an O 2 -sensitive membrane, and a two-channel optochemical measuring unit, which is connected to a computer for data collection (24) . On arrival, a microdialysis catheter (CMA60; CMA Microdialysis AB, Stockholm, Sweden) was inserted 6 to 8 cm lateral from the umbilicus, as described previously (7) . A second catheter was inserted in the FEM scAT (anterior site). After insertion, both catheters were perfused with Ringer solution (Baxter BV, Utrecht, Netherlands) at a flow rate of 2 mL/ min (CMA400 microinfusion pump; CMA Microdialysis AB). AT pO 2 was calculated by averaging a 30-minute period with stable pO 2 readings (change in AT pO 2 ,2.0 mm Hg).
ABD and FEM scATBF
ABD and FEM scATBF was measured under fasting conditions on the first visit using 133 Xe washout (7, 25) . More specific, ATBF was continuously monitored 6 to 8 cm lateral from the umbilicus (ABD) and at the anterior site of the upper leg (FEM), contralateral to the sites of insertion of the microdialysis probes. Quantitative values of ATBF were calculated as described previously (25) .
Hyperinsulinemic-euglycemic clamp
A hyperinsulinemic-euglycemic clamp was performed on the second visit to assess whole-body insulin sensitivity (26) . Insulin was infused at a primed continuous infusion rate of 40 mU•m
22
•min 21 . The mean glucose infusion rate during the steady state (last 30 minutes) of the clamp was used to determine insulin sensitivity.
AT biopsy specimens
ABD and FEM scAT needle biopsy specimens (;1 g) were collected 6 to 8 cm lateral from the umbilicus and from the FEM region (anterior site of the upper leg), respectively, under local anesthesia (2% lidocaine) after an overnight fast on the second visit. Biopsy specimens were immediately rinsed with sterile saline and visible blood vessels were removed with sterile tweezers. AT was fixed overnight in 4% paraformaldehyde and embedded in paraffin for histology. Another part was used for isolation of hMADS cells, as described before (27) . The remaining tissue was snap-frozen in liquid nitrogen and stored at 280°C for gene expression analysis.
Adipocyte morphology
Histological sections (8 mm) were cut from paraffinembedded tissue, mounted on microscope glass slides, and dried overnight in an incubator at 37°C. Sections were stained with hematoxylin and eosin. Digital images were captured with the use of a Leica DFC320 digital camera (Leica, Rijswijk, Netherlands) at 320 magnification (Leica DM3000 microscope; Leica). Computerized morphometric analysis (Leica QWin V3, Cambridge, England) of individual adipocytes was performed by measuring ;400 adipocytes per sample.
AT and adipocyte gene expression analysis
Total RNA was extracted from frozen AT specimens (;150 mg) and hMADS cells using TRIzol reagent (Invitrogen, Breda, Netherlands), and SYBR-Green-based real-time PCRs were performed using an iCycler (Bio-Rad, Veenendaal, Netherlands; primer sequences shown in Supplemental Table 1). Results were normalized to the geometric mean of 18S ribosomal RNA and RPL13A.
Human primary cell culture experiments hMADS cells, an established human white adipocyte model (27) , were obtained from ABD and FEM scAT of the same participants who also underwent the in vivo measurements. Cells were seeded at a density of 2000 cells/cm 2 and kept in proliferation medium under 21% O 2 and thereafter differentiated under 21%, 10%, or 5% O 2 for 14 days, as described previously (28) . Gas mixtures were refreshed every 8 hours (to maintain variation ,0.1% O 2 ), whereas medium was refreshed two to three times per week. In our hands, 10% and 5% O 2 approximate the average ABD scAT pO 2 values in obese and lean participants, respectively (7) . Because the potential differences in pO 2 between obese and lean FEM scAT are currently unknown, we decided to expose hMADS cells derived from FEM and ABD scAT to similar O 2 levels (21% O 2 , room air; 10% O 2 , high physiological pO 2 ; 5% O 2 , low physiological pO 2 ) for 14 days.
All experiments were performed under 21% O 2 on day 14 of the adipogenic differentiation. For gene expression analyses and measurement of adipokine secretion, the individual hMADS cells from all donors were used. For the oxygen consumption and glucose uptake experiments, a hMADS cell pool (consisting of three donors from this study) from both ABD and FEM scAT was used.
Adipokine secretion measurement
The medium of the hMADS cells was collected over 24 hours to determine adipokine secretion using high-sensitive ELISA (ELISA kits were purchased: adiponectin from Biovendor, IL-6 and MCP-1 from Diaclone, and leptin and DPP-4 from R&D Systems). If necessary, samples were diluted with a provided dilution buffer from the manufacturer prior to the assay, which was performed in duplicates, according to the manufacturer's instructions.
ABD and FEM adipocyte oxygen consumption
OCR, reflecting mitochondrial respiration, was measured in differentiated hMADS cells using a XF96 analyzer (Seahorse Bioscience, North Billerica, MA). Just before the measurement, cells were washed with unbuffered DMEM.
A bioenergetics profile was determined using a four-step analysis: (1) basal OCR was measured in medium containing (17.5 mM) glucose (Sigma) (calculated by the average respiration at the end of step 1 subtracted by the respiration after step 4), (2) ATP production rate and respiration driving proton leak were determined by measuring OCR after inhibition of ATP synthase by oligomycin (1.4 mM; Sigma) (calculated by the average of respiration at the end of step 1 subtracted by the respiration after step 2), (3) maximal mitochondrial respiratory capacity was assessed by measuring OCR after stimulation with the uncoupling agent carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (0.3 mM; Sigma) (calculated by the respiration at the end of step 3 subtracted by the respiration after step 4), and (4) nonmitochondrial respiration was assessed by measuring OCR after addition of complex I inhibitor: antimycin A/rotenone (1 mM; Sigma) (calculated by the average respiration at the end of step 4).
Glucose uptake in ABD and FEM adipocytes
Basal glucose uptake was measured in differentiated hMADS cells using 2-deoxy-D-glucose following serum starvation for 18 hours in DMEM low glucose, as described before (27) .
Statistical analyses
Data are presented as mean 6 SEM. AT depot differences were analyzed using the Student paired t test. The effects of different oxygen exposure levels on adipocyte gene expression, adipokine secretion, adipocyte oxygen consumption, and adipocyte glucose uptake were analyzed using the Kruskal-Wallis test, followed by post hoc comparison using the Wilcoxon signed-rank test. Calculations were performed with SPSS version 24 for Macintosh (SPSS, Inc., Chicago, IL). P , 0.05 was considered statistically significant.
Results
Participants' characteristics are shown in Table 1 . By design, the participants who were overweight/have obesity (BMI, 34.4 6 1.6 kg/m 2 ) included in the current study had an impaired glucose metabolism. pO 2 is higher in ABD than FEM AT ABD AT pO 2 was significantly higher than FEM AT pO 2 (62.7 6 6.6 vs 50.0 6 4.5 mm Hg, P = 0.013) (Fig. 1A) . ATBF was not significantly different between ABD and FEM AT (1.8 6 0.3 vs 2.8 6 0.5 mL 100 g tissue 21 min 21 , respectively, P = 0.122) (Fig. 1B) , indicating that a differential OCR between depots underlies the in vivo depot differences in AT pO 2 .
AT depot differences in adipocyte morphology ABD adipocytes were significantly smaller compared with FEM adipocytes (Fig. 2A) . Moreover, the smaller mean adipocyte size in ABD AT was explained by a shift toward a lower frequency of very large adipocytes and a higher frequency of very small adipocytes compared with FEM AT (Fig. 2B ).
ABD and FEM AT gene expression
Next, we assessed the gene expression profile of metabolic and inflammatory markers in ABD and FEM AT. Gene expression of the proinflammatory markers TNF-a, IL-6, DPP-4, PAI-1, MCP-1, and CD68 showed no significant differences between both AT depots (Fig. 2C) . However, ABD AT, characterized by smaller adipocytes, was accompanied by a significantly higher gene expression of adipogenic (adiponectin, PPARg), mitochondrial (PGC-1a), and lipolytic (ATGL, HSL) markers compared with FEM AT (Fig. 2C ).
Low physiological pO 2 decreases proinflammatory gene expression in adipocytes
To investigate whether microenvironmental pO 2 affects gene expression in human adipocytes, we exposed hMADS cells derived from ABD and FEM scAT to low and high physiological pO 2 (5% and 10% O 2 , respectively). Adipocyte differentiation in hMADS cells was induced under all pO 2 conditions, as reflected by increased PPARg expression at days 3, 7, and 14 vs day 0 (Fig. 3A) . Moreover, exposure to low and high physiological pO 2 did not significantly alter PPARg expression compared with 21% O 2 , suggesting no difference in adipogenic differentiation between pO 2 conditions (Fig. 3A) .
Low physiological AT pO 2 (5% O 2 ) markedly decreased gene expression of several proinflammatory markers in both ABD and FEM adipocytes (Fig. 3) . More specifically, gene expression of the proinflammatory markers IL-6 (Fig. 3C) , DPP-4 (Fig. 3D) , and PAI-1 (Fig. 3E) , as well as VEGFA (Fig. 3J) and GLUT1 (Fig. 3K) 
Microenvironmental pO 2 affects adipokine secretion in human adipocytes
Next, we investigated whether the changes in ABD and FEM adipocyte gene expression following exposure to physiological pO 2 translate into functional changes in adipokine secretion. Indeed, adipokine secretion from ABD and FEM adipocytes was substantially affected by oxygen availability (Fig. 4) . Specifically, exposure to 5% O 2 evoked a reduction of leptin (Fig. 4A ) and an increase in IL-6 secretion (Fig. 4B ) compared with 10% and 21% O 2 in a AT depot-independent manner. Moreover, low physiological pO 2 (5% O 2 ) tended to increase the secretion of the insulin-sensitizing factor adiponectin in FEM adipocytes compared with 21% and 10% O 2 (both P = 0.068, Fig. 4C ). No significant differences in the secretion of DPP-4 ( Fig. 4D ) and MCP-1 (Fig. 4E ) from ABD and FEM adipocytes were found following the different oxygen exposure regimens.
OCR is lower in ABD than FEM adipocytes
Because ATBF, which determines AT oxygen supply, was not significantly different between ABD and FEM AT, we next investigated whether differences in the metabolic rate of adipocytes underlie the higher AT pO 2 in ABD than FEM scAT. Indeed, OCR was lower in ABD compared with FEM adipocytes, where most pronounced effects are shown under lower physiological oxygen (5% O 2 ) (Fig. 5A-5F ). Moreover, ABD adipocytes showed reduced ATP turnover (measured by basal oligomycin), maximal respiratory capacity, and (Fig. 5C-5F ), where in the 21% O 2 condition, only maximal respiratory capacity was significantly lower in ABD adipocytes ( Fig. 5A and 5B).
Low physiological pO 2 increases glucose uptake in FEM adipocytes Next, we assessed whether prolonged exposure of differentiating hMADS cells to physiological pO 2 induces alterations in basal glucose uptake in ABD and FEM adipocytes. Although exposure of adipocytes to 10% O 2 did not significantly alter basal glucose uptake compared with 21% O 2 , low physiological pO 2 (5% O 2 ) showed a trend toward an increased basal glucose uptake in FEM adipocytes but not in ABD adipocytes. Moreover, after exposure of hMADS cells to low physiological pO 2 (5% O 2 ), FEM adipocytes showed significantly higher basal glucose uptake compared with ABD adipocytes (Supplemental Fig. 1) .
Discussion
In the current study, we compared in vivo ABD and FEM scAT pO 2 in women who are overweight/have obesity with impaired glucose metabolism, and performed mechanistic experiments to investigate the effects of prolonged physiological AT pO 2 exposure on ABD and FEM adipocyte metabolism and inflammation. Here, we demonstrate for the first time, to our knowledge, that in vivo AT pO 2 is higher in ABD compared with FEM AT, which seems to be explained by a lower OCR in ABD than FEM adipocytes. Moreover, prolonged exposure to low physiological AT pO 2 altered gene expression, adipokine secretion, mitochondrial OCR, and glucose uptake in human adipocytes, demonstrating that microenvironmental oxygen availability in AT affects human adipocyte function. Differences in the functional properties between AT depots may underlie the cardiometabolic risk associated with a certain body fat distribution pattern. The functional differences between ABD and FEM AT seem to emerge from adipocytes having distinct properties (21) . In the current study, we found that ABD AT constitutes smaller adipocytes than FEM AT in postmenopausal women with obesity, which is in agreement with most (29-31) but not all (32, 33) previous reports. Lower body AT is characterized by a lower lipid mobilization than upper body AT (34, 35) . A higher lipolytic rate in ABD AT may thus contribute to the smaller adipocytes in this depot. In line, we found that gene expression of ATGL and HSL was significantly higher in ABD than FEM AT. Furthermore, adiponectin, PGC-1a, and PPARg were expressed at a higher level in ABD AT. Although hypertrophic adipocytes are characterized by a proinflammatory phenotype, we did not find differences in inflammatory gene expression between ABD and FEM AT depots. Moreover, we found a tendency for increased expression of VEGFA, the master regulator of vasculogenesis, angiogenesis, and remodeling of blood vessels (36) in ABD AT, although this did not translate into differences in ATBF. Taken together, ABD AT is characterized by smaller adipocytes and a distinct pattern of gene expression with higher expression of adipogenic, lipolytic, and mitochondrial genes compared with FEM AT, whereas no differences were observed in inflammatory gene expression.
The local AT microenvironment may have a profound impact on the adipocyte phenotype. Accumulating evidence suggests that AT oxygenation may affect AT function (4) . Interestingly, we found that in vivo AT oxygenation was significantly higher in ABD than FEM AT in postmenopausal women who are overweight/ have obesity. We have previously demonstrated that ABD AT pO 2 was significantly higher in individuals with obesity and are insulin-resistant, compared with lean insulin-sensitive individuals, and was inversely associated with in vivo whole-body insulin sensitivity (7), independently of adiposity in men and women with obesity (8) . This raises the question of whether the differences in ABD and FEM AT pO 2 that we found in the current study may underlie the different functional properties of these AT depots.
First, to determine whether AT pO 2 affects gene expression of metabolic markers and adipokines, we exposed differentiating hMADS cells from ABD and FEM AT to low (5%) and high (10%) physiological pO 2 . Interestingly, we demonstrated that low physiological pO 2 during adipogenesis consistently reduced the expression of the proinflammatory markers IL-6, DPP-4, and PAI-1 in both FEM and ABD adipocytes, as well as leptin expression in ABD adipocytes. Thus, the lower in vivo pO 2 in FEM compared with ABD scAT, which reduces adipocyte gene expression of proinflammatory markers, may protect against a proinflammatory phenotype of hypertrophic FEM scAT in women with obesity. Noteworthy, we have previously found that in vivo ABD scAT pO 2 was positively associated with AT gene expression of several proinflammatory parameters (7) .
Next, we assessed whether the pO 2 -induced alterations in adipocyte gene expression translate into changes in adipokine secretion. Interestingly, low physiological pO 2 decreased leptin secretion in both ABD and FEM adipocytes and tended to increase the secretion of the insulin-sensitizing factor adiponectin in FEM adipocytes. In contrast to the decrease in IL-6 gene expression, we found that IL-6 secretion was increased following exposure to 5% O 2 during adipogenic differentiation in both depots. In addition, Famulla et al. (17) have shown opposite results of leptin and IL-6 secretion in differentiating adipocytes derived from healthy lean women, suggesting that donor characteristics may also influence the effects of pO 2 on the adipocyte phenotype.
Next, we questioned why AT pO 2 is higher in ABD than FEM AT. Because ATBF was not significantly different between ABD and FEM AT (if anything, lower in ABD AT), it seems that lower O 2 consumption may underlie the higher AT pO 2 in ABD compared with FEM AT. Indeed, maximal respiratory capacity was significantly lower in ABD than FEM adipocytes, independent of O 2 exposure level, where physiological O 2 also induced lower ATP turnover and nonmitochondrial respiration in ABD compared with FEM adipocytes. Moreover, cells that differentiated at low physiological pO 2 (5% O 2 ) showed a most robust increase in oxygen consumption for the different states in FEM adipocytes. These data indicate that human primary adipocytes retain, at least to a certain extent, intrinsic differences in the metabolic rate of adipocytes in vitro. In line, preadipocytes from different AT depots exert distinct functions and maintain their memory of origin in vitro (37) . Moreover, associations between the in vivo and in vitro phenotype of adipocytes were found, indicating inherent characteristics of adipocytes (38, 39) . Although it is likely that other cell types (e.g., immune cells) within AT contribute to oxygen consumption in AT, the present in vitro data clearly indicate differences in ABD and FEM adipocytes. Depot differences in adipocyte size do not seem to underlie the differences in OCR because it has previously been shown that interindividual differences in adipocyte oxygen consumption are independent of adipocyte size (40) .
Finally, we investigated whether prolonged exposure of differentiating hMADS cells to low and high physiological pO 2 exerts effects on glucose handling in ABD and FEM adipocytes. We found that low physiological pO 2 (5% O 2 ) tended to increase basal glucose uptake compared with 21% and 10% O 2 in FEM adipocytes.
Moreover, basal glucose uptake was higher in FEM than ABD adipocytes after exposure of hMADS cells to low physiological pO 2 (5% O 2 ). Thus, AT oxygenation seems to affect glucose uptake in differentiated human FEM adipocytes.
A strength of the current study is the detailed, paired comparisons between ABD and FEM scAT as well as the differentiated hMADS cells derived from these AT depots. Future studies should investigate whether AT depot differences in oxygenation also exist in other populations than obese postmenopausal women. A limitation is that measurements of OCR and glucose uptake following prolonged exposure (14 days) to 5%, 10%, or 21% O 2 were performed under 21% O 2 , which might have blunted the effects of physiological oxygen exposure to a certain extent.
In conclusion, we demonstrated for the first time, to our knowledge, that AT pO 2 is higher in ABD than FEM scAT in postmenopausal women who are overweight/ have obesity, which seems to be explained by a lower OCR in ABD adipocytes. Moreover, low physiological pO 2 decreased proinflammatory gene expression and improved the metabolic phenotype in differentiated human adipocytes, whereas more heterogeneous effects on adipokine secretion were found. Together, the present findings suggest that altered microenvironmental pO 2 may modulate AT function in human obesity. Therefore, AT oxygenation may be a putative target to improve AT dysfunction and related cardiometabolic complications in obese individuals. Future studies are warranted to investigate whether modulation of AT pO 2 may improve the cardiometabolic risk in human obesity.
